Free tool
FAERS Monitor: Soma
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 011792 or its brand name (Soma, Carisoprodol). Reports on generic versions are filed under their own applications.
Reports
19,021
Serious
13,059
69% of reports
Hospitalization
4,651
Death reported
4,017
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pain1,624
- completed suicide1,459
- drug ineffective1,319
- nausea1,294
- headache1,102
- anxiety992
- depression990
- fatigue989
- toxicity to various agents917
- insomnia829
- vomiting819
- drug dependence797
- fall789
- dyspnoea747
- overdose734
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 607 |
| 2005 | 750 |
| 2006 | 601 |
| 2007 | 511 |
| 2008 | 671 |
| 2009 | 763 |
| 2010 | 1,289 |
| 2011 | 1,148 |
| 2012 | 1,433 |
| 2013 | 1,160 |
| 2014 | 978 |
| 2015 | 1,366 |
| 2016 | 1,602 |
| 2017 | 1,086 |
| 2018 | 1,085 |
| 2019 | 1,059 |
| 2020 | 1,034 |
| 2021 | 600 |
| 2022 | 354 |
| 2023 | 275 |
| 2024 | 268 |
| 2025 | 207 |
| 2026 | 173 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,138 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 1,459 | 19.7 | 18.7 | 25,510 |
| toxicity to various agentsSignal | 917 | 6.0 | 5.7 | 3,862 |
| drug dependenceSignal | 797 | 5.5 | 5.1 | 2,940 |
| depressionSignal | 990 | 4.8 | 4.5 | 3,020 |
| anxietySignal | 992 | 3.9 | 3.6 | 2,125 |
| overdoseSignal | 734 | 3.8 | 3.5 | 1,503 |
| insomniaSignal | 829 | 3.4 | 3.2 | 1,453 |
| painSignal | 1,624 | 2.9 | 2.8 | 2,117 |
| fallSignal | 789 | 2.6 | 2.5 | 803 |
| headache | 1,102 | 1.9 | 1.8 | 520 |
| vomiting | 819 | 1.9 | 1.8 | 372 |
| nausea | 1,294 | 1.8 | 1.7 | 485 |
| dyspnoea | 747 | 1.5 | 1.4 | 111 |
| fatigue | 989 | 1.4 | 1.3 | 119 |
| drug ineffective | 1,319 | 1.1 | 1.1 | 14 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.